Association of ESR1 gene tagging SNPs with breast cancer risk.

Alison M Dunning; Catherine S Healey; Caroline Baynes; Ana-Teresa Maia; Serena Scollen; Ana Vega; Raquel Rodríguez; Nuno L Barbosa-Morais; Bruce AJ Ponder; SEARCH; +89 more... Yen-Ling Low; Sheila Bingham; EPIC; Christopher A Haiman; Loic Le Marchand; MEC; Annegien Broeks; Marjanka K Schmidt; ABCS; John Hopper; Melissa Southey; ABCFS; Matthias W Beckmann; Peter A Fasching; BBCC; Julian Peto ORCID logo; Nichola Johnson; BBCS; Stig E Bojesen; Børge Nordestgaard; CGPS; Roger L Milne; Javier Benitez; CNIO-BCS; Ute Hamann; Yon Ko; GENICA; Rita K Schmutzler; Barbara Burwinkel; GC-HBOC; Peter Schürmann; Thilo Dörk; HABCS; Tuomas Heikkinen; Heli Nevanlinna; HEBCS; Annika Lindblom; Sara Margolin; KARBAC; Arto Mannermaa; Veli-Matti Kosma; KBCS; Xiaoqing Chen; Amanda Spurdle; kConFab and the AOCS Management Group; Jenny Change-Claude; Dieter Flesch-Janys; MARIE; Fergus J Couch; Janet E Olson; for MCBCS; Gianluca Severi; Laura Baglietto; MCCS; Anne-Lise Børresen-Dale; Vessela Kristensen; NBCS; David J Hunter; Susan E Hankinson; NHS; Peter Devilee; Maaike Vreeswijk; ORIGO; Jolanta Lissowska; Louise Brinton; PBCS; Jianjun Liu; Per Hall; SASBAC; Daehee Kang; Keun-Young Yoo; SEBCS; Chen-Yang Shen; Jyh-Cherng Yu; TWBCS; Hoda Anton-Culver; Argyrios Ziogoas; UCIBCS; Alice Sigurdson; Jeff Struewing; USRTS; Douglas F Easton; Montserrat Garcia-Closas; Manjeet K Humphreys; Jonathan Morrison; Paul DP Pharoah; Karen A Pooley; Georgia Chenevix-Trench; BCAC; (2009) Association of ESR1 gene tagging SNPs with breast cancer risk. Human molecular genetics, 18 (6). pp. 1131-1139. ISSN 0964-6906 DOI: 10.1093/hmg/ddn429
Copy

We have conducted a three-stage, comprehensive single nucleotide polymorphism (SNP)-tagging association study of ESR1 gene variants (SNPs) in more than 55,000 breast cancer cases and controls from studies within the Breast Cancer Association Consortium (BCAC). No large risks or highly significant associations were revealed. SNP rs3020314, tagging a region of ESR1 intron 4, is associated with an increase in breast cancer susceptibility with a dominant mode of action in European populations. Carriers of the c-allele have an odds ratio (OR) of 1.05 [95% Confidence Intervals (CI) 1.02-1.09] relative to t-allele homozygotes, P = 0.004. There is significant heterogeneity between studies, P = 0.002. The increased risk appears largely confined to oestrogen receptor-positive tumour risk. The region tagged by SNP rs3020314 contains sequence that is more highly conserved across mammalian species than the rest of intron 4, and it may subtly alter the ratio of two mRNA splice forms.

Full text not available from this repository.

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads